Open AccessImmunotherapy with pembrolizumab in a patient with advanced non-small-cell lung cancer with high PD-L1 expression and MET exon 14 splice site mutation: a case report
Author(s) -
Paulina Terlecka,
Paweł Krawczyk,
Anna Grenda,
Izabela Chmielewska,
Janusz Milanowski
Publication year - 2022
Publication title -
oncology in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 2450-6478
pISSN - 2450-1654
DOI - 10.5603/ocp.2022.0007
Subject(s) - pembrolizumab , medicine , lung cancer , oncology , discontinuation , immunotherapy , adenocarcinoma , cancer , radiation therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom